Outcome of 12-month surveillance colonoscopy in high-risk patients in the national health service bowel cancer screening programme

Colorectal Disease

Volumn 15, Issue 8, 2013, Pages

  Lee, T J W ^a,b,c   Nickerson, C ^d   Goddard, A F ^e   Rees, C J ^c,f,g   Mcnally, R J Q ^a   Rutter, M D ^b,c,g  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^c Northern Region Endoscopy Group   (United Kingdom)

^d NATIONAL HEALTH SERVICE   (United Kingdom)

^e DERBY CITY GENERAL HOSPITAL   (United Kingdom)

^f SOUTH TYNESIDE DISTRICT HOSPITAL   (United Kingdom)

^g DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Cancer; Colonoscopy; Epidemiology

Indexed keywords

ADULT; ADVANCED CANCER; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER SCREENING; CLINICAL FEATURE; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; DISEASE SURVEILLANCE; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; OUTCOME ASSESSMENT; OUTCOME VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING HABIT; VILLOUS ADENOMA;

CANCER; COLONOSCOPY; EPIDEMIOLOGY;

ADENOMA; AGED; COLONIC NEOPLASMS; COLONOSCOPY; EARLY DETECTION OF CANCER; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; RISK FACTORS; STATE MEDICINE;

EID: 84883220088     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12278     Document Type: Article

References (30)

1. Office for National Statistics Mortality Statistics: Cause. England and Wales 2008 London TSO 2010
2. Morson B. President's address: the polyp-cancer sequence in the large bowel. Proc R Soc Med 1974; 67: 451-7.
3. Winawer S, Zauber A, O'Brien M et al. Prevention of colorectal cancer by colonoscopies polypectomy. N Engl J Med 1993; 329: 1977-81.
4. Zauber AG, Winawer SJ, O'Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366: 687-96.
5. Waye J, Braunfeld S. Surveillance intervals after colonoscopic polypectomy. Endoscopy 1982; 14: 79-81 (Category: III).
6. Winawer S, Zauber A, O'Brien M et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993; 328: 901-6.
7. Atkin W, Williams C, Macrae F et al. Randomised study of surveillance intervals after removal of colorectal adenomas at colonoscopy. Gut 1992; 33: S52.
8. Cairns SR, Scholefield JH, Steele RJ et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010; 59: 666-90.
9. Eide T. Risk of colorectal cancer in adenoma bearing individuals within a defined population. Int J Cancer 1986; 38: 173-6.
10. Martinez ME, Sampliner R, Marshall JR et al. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 2001; 120: 1077-83.
11. Noshirwani C, VanStolk U, Rybicki L et al. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 2000; 51: 433-7.
12. Saini SD, Hyungjin MK, Schoenfeld P et al. Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc 2006; 64: 614-26.
13. Martinez ME, Baron JA, Lieberman DA et al. A pooled analysis of advanced colorectal neoplasia diagnosis after colonoscopic polypectomy. Gastroenterology 2009; 136: 832-41.
14. de Jonge V, Sint Nicolaas J, van Leerdam ME et al. Systematic literature review and pooled analyses of risk factors for finding adenomas at surveillance colonoscopy. Endoscopy 2011; 43: 560-72.
15. Lee TJW, Rutter MD, Blanks RG et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut 2012; 61: 1050-7.
16. van Rijn JC, Reitsma JB, Stoker J et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006; 101: 343-50.
17. Robertson D, Greenberg E, Beach M et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005; 129: 34-41.
18. Arber N, Eagle C, Spicak J et al. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006; 355: 885-95.
19. Costantini M, Sciallero S, Giannini A et al. Interobserver agreement in the histologic diagnosis of colorectal polyps. The experience of the multicentre adenoma colorectal study (SMAC). J Clin Epidemiol 2003; 56: 209-14.
20. Smith RA, Cokkinides V, von Eschenbach AC et al. American cancer society guidelines for early detection of cancer. CA Cancer J Clin 2002; 52: 8-22.
21. Bond JH. Polyp guideline, treatment and surveillance for patients with colorectal polyps: Practice parameters committee of the American College of Gastroenterology. Am J Gastroenterol 2000; 95: 3053-63.
22. Baxter NN, Goldwasser MA, Paszat MF et al. Association of colonoscopy and death from colorectal cancer: a population based case-controlled study. Ann Intern Med 2009; 150: 1-8.
23. Brenner H, Hoffmeister M, Arndt V et al. Protection from right - and left- sided colorectal neoplasms after colonoscopy: population based study. J Natl Cancer Inst 2010; 102: 89-95.
24. Singh H, Turner D, Xue L et al. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006; 295: 2366-73.
25. Nawa T, Kato J, Kawamoto H et al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol 2008; 23: 418-23.
26. Arain MA, Sawhney M, Sheikh S et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 2010; 105: 1189-95.
27. National Cancer Intelligence Network. (2009) Colorectal Cancer Survival by Stage. NCIN Data Briefing, London.
28. Logan RFA, Patnick J, Nickerson C et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012; 61: 1439-46.
29. Hardcastle JD, Chamberlain JO, Robinson MHE et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
30. Segnan N, Patnick J, von Karsa L (eds). (2011 1st edition) European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. Publishing office of the European Union, Luxemburg.